Compare Cigna Corp (CI) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $59.79. The key difference: Cigna Corp pays a 2.24% dividend while JPMorgan Nasdaq Equity Premium Income ETF pays none, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Cigna Corp nearer its low. Which is the better fit depends on your goals.
| CI | JEPQ | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $311.00 | $61.46 |
52-Week Low | $244.41 | $53.77 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
JEPQ trades at $59.74, up 0.67% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on Nasdaq-linked covered call strategies for income, with recent dividends including $0.70 in July 2026. Support and resistance cluster tightly around $59-$60, indicating consolidation near current levels.
Outlook remains income-focused with steady distributions, though tax implications and Nasdaq volatility pose risks. Institutional interest is strong, but overbought RSI signals caution for near-term entries. The strategy appeals to retirees seeking monthly cash flow but may lag in strong bull markets due to capped upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
